Citations

Mayo Clinic

Clear

1933 citation(s) found for "Wu, Albert W".

Proton pump inhibitor-responsive oesophageal eosinophilia: an entity challenging current diagnostic criteria for eosinophilic oesophagitis
Molina‐Infante, Javier , Bredenoord, Albert J. , Cheng, Edaire , Dellon, Evan S. , Furuta, Glenn T. , Gupta, Sandeep K. , Hirano, Ikuo , Katzka, David A. , Moawad, Fouad J. , Schoepfer, Alain , Wen, Ting , Straumann, Alex , Rothenberg, Marc E. , Spechler, Stuart Jon , Lucendo, Alfredo

Gut | December 19, 2015 | Volume: 65 | Issue: 3 | Pages: 524-531

10.1136/gutjnl-2015-310991 | PMID 26685124 Get It

Consensus diagnostic recommendations to distinguish GORD from eosinophilic oesophagitis (EoE) by response to a trial of proton pump inhibitors (PPIs) unexpectedly uncovered an entity called ‘PPI-responsive oesophageal eosinophilia’ (PPI-REE). PPI-REE refers to patients with clinical and histological features of EoE that remit with PPI treatment. Recent and evolving evidence, mostly from adults, shows that patients with PPI-REE and patients with EoE at baseline are clinically, endoscopically and histologically indistinguishable and have a significant overlap in terms of features of Th2 immune-mediated inflammation and gene expression. Furthermore, PPI therapy restores oesophageal mucosal integrity, reduces Th2 inflammation and reverses the abnormal gene expression signature in patients with PPI-REE, similar to the effects of topical steroids in patients with EoE. Additionally, recent series have reported that patients with EoE responsive to diet/topical steroids may also achieve remission on PPI therapy. This mounting evidence supports the concept that PPI-REE represents a continuum of the same immunological mechanisms that underlie EoE. Accordingly, it seems counterintuitive to differentiate PPI-REE from EoE based on a differential response to PPI therapy when their phenotypic, molecular, mechanistic and therapeutic features cannot be reliably distinguished. For patients with symptoms and histological features of EoE, it is reasonable to consider PPI therapy not as a diagnostic test, but as a therapeutic agent. Due to its safety profile, ease of administration and high response rates (up to 50%), PPI can be considered a first-line treatment before diet and topical steroids. The reasons why some patients with EoE respond to PPI, while others do not, remain to be elucidated.
P1‐319: Alzheimer's prevention registry: A shared resource to the scientific community to facilitate enrollment in studies
High, Nellie, Reiman, Eric M. , Aisen, Paul, Albert, Marilyn S. , Comer, Meryl, Petersen, Ronald , Strobel, Gabrielle, Weiner, Michael W. , Tariot, Pierre N. , Langbaum, Jessica B. S. , Cummings, Jeffrey L. , Manly, Jennifer J. , Sperling, Reisa Anne

Alzheimer's & Dementia | December 15, 2015 | Volume: 11 | Issue: 7S_Part_10 | Pages: No page available

10.1016/j.jalz.2015.06.534 Get It

The Sphenopalatine Ganglion: Anatomy, Pathophysiology, and Therapeutic Targeting in Headache
Robertson, Carrie E. , Kaplan, Eugene D. , Kuruvilla, Deena E. , Blumenfeld, Andrew , Berliner, Randall, Rosen, Noah , Duarte, Robert , Vidwan, Jaskiran, Halker, Rashmi, Gill, Nicole, Halker, Rashmi B, Robbins, Matthew S. , Ailani, Jessica , Charleston, Larry , Ashkenazi, Avi , Robertson, Carrie E

Headache: The Journal of Head and Face Pain | November 30, 2015 | Volume: 56 | Issue: 2 | Pages: 240-258

10.1111/head.12729 | PMID 26615983 Get It

The sphenopalatine ganglion (SPG) has attracted the interest of practitioners treating head and face pain for over a century because of its anatomical connections and role in the trigemino‐autonomic reflex. In this review, we discuss the anatomy of the SPG, as well as what is known about its role in the pathophysiology of headache disorders, including cluster headache and migraine. We then address various therapies that target the SPG, including intranasal medication delivery, new SPG blocking catheter devices, neurostimulation, chemical neurolysis, and ablation procedures.
Hemodynamic Characterization of Geometric Cerebral Aneurysm Templates Treated With Embolic Coils
Nair, Priya , Chong, Brian W. , Indahlastari, Aprinda , Workman, Christopher , Babiker, M. Haithem, Farsani, Hooman Yadollahi, Baccin, Carlos E. , Frakes, David , Ryan, Justin

Journal of Biomechanical Engineering | November 23, 2015 | Volume: 138 | Issue: 2 | Pages: No page available

10.1115/1.4032046 | PMID 26593324 Get It

Embolic coiling is one of the most effective treatments for cerebral aneurysms (CAs), largely due to the hemodynamic modifications that the treatment effects in the aneurysmal environment. However, coiling can have very different hemodynamic outcomes in aneurysms with different geometries. Previous work in the field of biofluid mechanics has demonstrated on a general level that geometry is a driving factor behind aneurysmal hemodynamics. The goal of this study was to relate two specific geometric factors that describe CAs (i.e., dome size (DS) and parent-vessel contact-angle (PV-CA)) and one factor that describes treatment (i.e., coil packing density (PD)) to three clinically relevant hemodynamic responses (i.e., aneurysmal root-mean-square velocity (Vrms), aneurysmal wall shear stress (WSS), and cross-neck flow (CNF)). Idealized models of basilar tip aneurysms were created in both virtual and physical forms to satisfy two-level multifactorial experimental designs. Steady and pulsatile flow hemodynamics were then evaluated in the virtual models using computational fluid dynamics (CFD) (before and after virtual treatment with finite element (FE) embolic coil models), and hemodynamics were also evaluated in the physical models using particle image velocimetry (PIV) (before and after treatment with actual embolic coils). Results showed that among the factors considered, PD made the greatest contributions to effects on hemodynamic responses in and around the aneurysmal sac (i.e., Vrms and WSS), while DS made the greatest contributions to effects on hemodynamics at the neck (i.e., CNF). Results also showed that while a geometric factor (e.g., PV-CA) may play a relatively minor role in dictating hemodynamics in the untreated case, the same factor can play a much greater role after coiling. We consider the significance of these findings in the context of aneurysmal recurrence and rupture, and explore potential roles for the proposed methods in endovascular treatment planning.
Caveolins, Liquid-Ordered Domains, and Signal Transduction
Smart, Eric J., Graf, Gregory A. , McNiven, Mark A. , Engelman, Jeffrey A. , Scherer, Philipp E. , Sessa, William C. , Okamoto, Takashi , Lisanti, Michael P.

Molecular and Cellular Biology | October 26, 2015 | Volume: 19 | Issue: 11 | Pages: 7289-7304

10.1128/mcb.19.11.7289 | PMID 10523618 Get It

Letter: treatment of autoimmune acute liver failure - beyond consensus guidelines; author's reply
Czaja, Albert J.

Alimentary Pharmacology & Therapeutics | October 13, 2015 | Volume: 38 | Issue: 9 | Pages: 1144-1144

10.1111/apt.12498 | PMID 24099481 Get It